TMEM167AP2: A Potential Drug Target and Biomarker (G100129118)

Target Name: TMEM167AP2

NCBI ID: G100129118

TMEM167AP2

Other Name(s): TMEM167A pseudogene 2 | Transmembrane protein 167A pseudogene | LOC100129118

TMEM167AP2: A Potential Drug Target and Biomarker

TMEM167AP2, also known as heat shock protein 70 (Hsp70), is a protein that is expressed in various tissues and cells throughout the body. It is a member of the Hsp70 family, which is known for its ability to withstand high levels of thermal stress and to participate in various cellular processes, including DNA replication, protein folding, and stress responses. The Hsp70 family has been implicated in a wide range of biological processes, including the regulation of cell growth, differentiation, and stress responses.

TMEM167AP2 has been identified as a potential drug target due to its involvement in a number of cellular processes that are associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Additionally, it has been shown to play a role in several cellular processes that are important for tissue repair and regeneration, such as the regulation of cell death and the response to physical exercise.

One of the key features of TMEM167AP2 is its ability to interact with a variety of different molecules, including drugs and other proteins. This makes it an attractive target for drug development because it allows researchers to test the efficacy of drugs on a wide range of cellular processes and to identify potential biomarkers for disease.

In addition to its potential as a drug target, TMEM167AP2 has also been shown to be a valuable biomarker for several diseases. For example, it has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, it has been associated with the development of certain types of cancer, such as lung and ovarian cancer.

The ability of TMEM167AP2 to interact with other proteins and drugs makes it an attractive target for drug development and research into the underlying mechanisms of disease. Further studies are needed to fully understand its role in these processes and to identify its potential as a drug target and biomarker.

Protein Name: TMEM167A Pseudogene 2

The "TMEM167AP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM167AP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets